Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study.

Abrahami D, Douros A, Yin H, Yu OH, Faillie JL, Montastruc F, Platt RW, Bouganim N, Azoulay L.

BMJ. 2018 Dec 5;363:k4880. doi: 10.1136/bmj.k4880.

2.

A Novel Self-Assembled Mitochondria-Targeting Protein Nanoparticle Acting as Theranostic Platform for Cancer.

Zhu XJ, Li RF, Xu L, Yin H, Chen L, Yuan Y, Zhong W, Lin J.

Small. 2018 Nov 19:e1803428. doi: 10.1002/smll.201803428. [Epub ahead of print]

PMID:
30450734
3.

Molecular monitoring of therapeutic milestones and clinical outcomes in patients with chronic myeloid leukemia.

Klil-Drori AJ, Yin H, Azoulay L, Del Corpo A, Harnois M, Gratton MO, Olney HJ, Delage R, Laneuville P, Mollica L, Busque L, Assouline SE; Groupe Québécois de Recherche en Leucémie Myéloïde Chronique et Néoplasies Myéloprolifératives (GQR LMC-NMP).

Cancer. 2018 Nov 13. doi: 10.1002/cncr.31835. [Epub ahead of print]

PMID:
30423211
4.

Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study.

Hicks BM, Filion KB, Yin H, Sakr L, Udell JA, Azoulay L.

BMJ. 2018 Oct 24;363:k4209. doi: 10.1136/bmj.k4209.

5.

Effects of glucocorticoids combined with probiotics in treating Crohn's disease on inflammatory factors and intestinal microflora.

Su H, Kang Q, Wang H, Yin H, Duan L, Liu Y, Fan R.

Exp Ther Med. 2018 Oct;16(4):2999-3003. doi: 10.3892/etm.2018.6559. Epub 2018 Aug 2.

6.

Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy.

Douros A, Filion KB, Yin H, Yu OH, Etminan M, Udell JA, Azoulay L.

Diabetes Care. 2018 Nov;41(11):2330-2338. doi: 10.2337/dc17-2280. Epub 2018 Aug 27.

PMID:
30150234
7.

Combination of 3D printing technologies and compressed tablets for preparation of riboflavin floating tablet-in-device (TiD) systems.

Fu J, Yin H, Yu X, Xie C, Jiang H, Jin Y, Sheng F.

Int J Pharm. 2018 Oct 5;549(1-2):370-379. doi: 10.1016/j.ijpharm.2018.08.011. Epub 2018 Aug 11.

PMID:
30107218
8.

Potential of near infrared spectroscopy and pattern recognition for rapid discrimination and quantification of Gleditsia sinensis thorn powder with adulterants.

Wang L, Hui Y, Jiang K, Yin G, Wang J, Yan Y, Wang Y, Li J, Wang P, Bi K, Wang T.

J Pharm Biomed Anal. 2018 Oct 25;160:64-72. doi: 10.1016/j.jpba.2018.07.036. Epub 2018 Jul 20.

PMID:
30064041
9.

Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes.

Douros A, Abrahami D, Yin H, Yu OHY, Renoux C, Hudson M, Azoulay L.

Epidemiology. 2018 Nov;29(6):904-912. doi: 10.1097/EDE.0000000000000891.

PMID:
30028343
10.

FgBud3, a Rho4-Interacting Guanine Nucleotide Exchange Factor, Is Involved in Polarity Growth, Cell Division and Pathogenicity of Fusarium graminearum.

Zhang C, Luo Z, He D, Su L, Yin H, Wang G, Liu H, Rensing C, Wang Z.

Front Microbiol. 2018 Jun 7;9:1209. doi: 10.3389/fmicb.2018.01209. eCollection 2018.

11.

Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study.

Abrahami D, Douros A, Yin H, Yu OHY, Renoux C, Bitton A, Azoulay L.

BMJ. 2018 Mar 21;360:k872. doi: 10.1136/bmj.k872.

12.

Coordination geometry of Zn2+ on hexagonal turbostratic birnessites with different Mn average oxidation states and its stability under acid dissolution.

Yin H, Wang X, Qin Z, Ginder-Vogel M, Zhang S, Jiang S, Liu F, Li S, Zhang J, Wang Y.

J Environ Sci (China). 2018 Mar;65:282-292. doi: 10.1016/j.jes.2017.02.017. Epub 2017 Mar 7.

PMID:
29548399
13.

Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Serious Liver Injury.

Douros A, Azoulay L, Yin H, Suissa S, Renoux C.

J Am Coll Cardiol. 2018 Mar 13;71(10):1105-1113. doi: 10.1016/j.jacc.2018.01.009.

PMID:
29519351
14.

MicroRNA-655 attenuates the malignant biological behaviours of retinoblastoma cells by directly targeting PAX6 and suppressing the ERK and p38 MAPK signalling pathways.

Zhang M, Li Q, Pan Y, Wang H, Liu G, Yin H.

Oncol Rep. 2018 Apr;39(4):2040-2050. doi: 10.3892/or.2018.6264. Epub 2018 Feb 13.

PMID:
29436689
15.

Tuning the Surface Composition of Ni/meso-CeO2 with Iridium as an Efficient Catalyst for Hydrogen Generation from Hydrous Hydrazine.

Qiu YP, Yin H, Dai H, Gan LY, Dai HB, Wang P.

Chemistry. 2018 Apr 3;24(19):4902-4908. doi: 10.1002/chem.201705923. Epub 2018 Mar 2.

PMID:
29368412
16.

Retinol dehydrogenase-10 promotes development and progression of human glioma via the TWEAK-NF-κB axis.

Guan F, Wang L, Hao S, Wu Z, Bai J, Kang Z, Zhou Q, Chang H, Yin H, Li D, Tian K, Ma J, Zhang G, Zhang J.

Oncotarget. 2017 Oct 27;8(62):105262-105275. doi: 10.18632/oncotarget.22166. eCollection 2017 Dec 1.

17.

Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes.

Abrahami D, Yin H, Yu OHY, Pollak MN, Azoulay L.

Epidemiology. 2018 Mar;29(2):246-253. doi: 10.1097/EDE.0000000000000793.

PMID:
29283894
18.

Enhanced photocatalytic H2-production activity of C-dots modified g-C3N4/TiO2 nanosheets composites.

Li Y, Feng X, Lu Z, Yin H, Liu F, Xiang Q.

J Colloid Interface Sci. 2018 Mar 1;513:866-876. doi: 10.1016/j.jcis.2017.12.002. Epub 2017 Dec 5.

PMID:
29227926
19.

Potential of transition metal atoms embedded in buckled monolayer g-C3N4 as single-atom catalysts.

Li SL, Yin H, Kan X, Gan LY, Schwingenschlögl U, Zhao Y.

Phys Chem Chem Phys. 2017 Nov 15;19(44):30069-30077. doi: 10.1039/c7cp05195f.

PMID:
29098219
20.

Sulfonylureas as Initial Treatment for Type 2 Diabetes and the Risk of Severe Hypoglycemia.

Yu O, Azoulay L, Yin H, Filion KB, Suissa S.

Am J Med. 2018 Mar;131(3):317.e11-317.e22. doi: 10.1016/j.amjmed.2017.09.044. Epub 2017 Oct 12.

PMID:
29032229
21.

Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events.

Douros A, Yin H, Yu OHY, Filion KB, Azoulay L, Suissa S.

Diabetes Care. 2017 Nov;40(11):1506-1513. doi: 10.2337/dc17-0595. Epub 2017 Sep 1.

PMID:
28864502
22.

Socioeconomic status and prevalence of chronic non-communicable diseases in Chinese women: a structural equation modelling approach.

Yin H, Wu Q, Cui Y, Hao Y, Liu C, Li Y, Liang L, Wang L, Tao Y.

BMJ Open. 2017 Aug 21;7(8):e014402. doi: 10.1136/bmjopen-2016-014402.

23.

Synthesis and anticancer properties of ruthenium (II) complexes as potent apoptosis inducers through mitochondrial disruption.

Wan D, Tang B, Wang YJ, Guo BH, Yin H, Yi QY, Liu YJ.

Eur J Med Chem. 2017 Oct 20;139:180-190. doi: 10.1016/j.ejmech.2017.07.066. Epub 2017 Jul 28.

PMID:
28800456
24.

Androgen Deprivation Therapy and the Risk of Anemia in Men with Prostate Cancer.

Hicks BM, Klil-Drori AJ, Yin H, Campeau L, Azoulay L.

Epidemiology. 2017 Sep;28(5):712-718. doi: 10.1097/EDE.0000000000000678.

PMID:
28768300
25.

A Combination of Testosterone and White Blood Cell Count as a Predictive Factor of Overall Survival in Localized Prostate Cancer.

Taussky D, Souliéres D, Azoulay L, Yin H, Bahig H, Bahary JP, Delouya G.

Target Oncol. 2017 Oct;12(5):695-701. doi: 10.1007/s11523-017-0516-3.

PMID:
28712059
26.

IL-33 improves wound healing through enhanced M2 macrophage polarization in diabetic mice.

He R, Yin H, Yuan B, Liu T, Luo L, Huang P, Dai L, Zeng K.

Mol Immunol. 2017 Oct;90:42-49. doi: 10.1016/j.molimm.2017.06.249. Epub 2017 Jul 8.

PMID:
28697404
27.

Foreign body ileitis: a histopathological mimic of Crohn's disease?

Krishnan S, Dill T, Simons D, Yin H.

Pathology. 2017 Aug;49(5):551-553. doi: 10.1016/j.pathol.2017.04.005. Epub 2017 Jul 6. No abstract available.

PMID:
28689632
28.

Early switch to second-line tyrosine kinase inhibitor in chronic myeloid leukemia patients failing to achieve early molecular response.

Klil-Drori AJ, Yin H, Azoulay L, Harnois M, Gratton MO, Del Corpo A, Olney HJ, Delage R, Laneuville P, Mollica L, Busque L, Assouline SE; Quebec CML Group.

Am J Hematol. 2017 Oct;92(10):E602-E604. doi: 10.1002/ajh.24838. Epub 2017 Jul 29. No abstract available.

29.

Graphene-coated nanowires with a drop-shaped cross section for 10  nm confinement and 1  mm propagation.

Huang Y, Zhang L, Yin H, Zhang M, Su H, Li IL, Liang H.

Opt Lett. 2017 Jun 1;42(11):2078-2081. doi: 10.1364/OL.42.002078.

PMID:
28569849
30.

Metformin and the incidence of viral associated cancers in patients with type 2 diabetes.

Hicks BM, Yin H, Sinyavskaya L, Suissa S, Azoulay L, Brassard P.

Int J Cancer. 2017 Jul 1;141(1):121-128. doi: 10.1002/ijc.30733. Epub 2017 Apr 24.

31.

Prolactin-Elevating Antipsychotics and the Risk of Endometrial Cancer.

Klil-Drori AJ, Yin H, Abenhaim HA, du Fort GG, Azoulay L.

J Clin Psychiatry. 2017 Jun;78(6):714-719. doi: 10.4088/JCP.15m10532.

PMID:
28199787
32.

Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia.

Hicks BM, Yin H, Bladou F, Ernst P, Azoulay L.

Thorax. 2017 Jul;72(7):596-597. doi: 10.1136/thoraxjnl-2016-209512. Epub 2016 Dec 16.

PMID:
27986803
33.

Androgen Deprivation Therapy and the Risk of Dementia in Patients With Prostate Cancer.

Khosrow-Khavar F, Rej S, Yin H, Aprikian A, Azoulay L.

J Clin Oncol. 2017 Jan 10;35(2):201-207. Epub 2016 Nov 21.

PMID:
27870566
34.

The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer.

Mandilaras V, Bouganim N, Yin H, Asselah J, Azoulay L.

Br J Cancer. 2017 Jan 3;116(1):103-108. doi: 10.1038/bjc.2016.375. Epub 2016 Nov 15.

35.

Synthesis, characterization and anticancer effect of the ruthenium (II) polypyridyl complexes on HepG2 cells.

Wan D, Lai SH, Yang HH, Tang B, Zhang C, Yin H, Zeng CC, Liu YJ.

J Photochem Photobiol B. 2016 Dec;165:246-255. doi: 10.1016/j.jphotobiol.2016.10.038. Epub 2016 Oct 31.

PMID:
27816647
36.
37.

Mechanisms on the morphology variation of hematite crystals by Al substitution: The modification of Fe and O reticular densities.

Li W, Liang X, An P, Feng X, Tan W, Qiu G, Yin H, Liu F.

Sci Rep. 2016 Oct 27;6:35960. doi: 10.1038/srep35960.

38.

Self-management behavior among patients with diabetic retinopathy in the community: a structural equation model.

Yang L, Wu Q, Hao Y, Cui Y, Liang L, Gao L, Jiao M, Ning N, Sun H, Kang Z, Han L, Li Y, Yin H.

Qual Life Res. 2017 Feb;26(2):359-366. doi: 10.1007/s11136-016-1396-1. Epub 2016 Sep 3.

PMID:
27592109
39.

Astragaloside IV alleviates E. coli-caused peritonitis via upregulation of neutrophil influx to the site of infection.

Huang P, Lu X, Yuan B, Liu T, Dai L, Liu Y, Yin H.

Int Immunopharmacol. 2016 Oct;39:377-382. doi: 10.1016/j.intimp.2016.08.011. Epub 2016 Aug 17.

PMID:
27543854
40.

Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus.

Faillie JL, Yu OH, Yin H, Hillaire-Buys D, Barkun A, Azoulay L.

JAMA Intern Med. 2016 Oct 1;176(10):1474-1481. doi: 10.1001/jamainternmed.2016.1531.

PMID:
27478902
41.

The associations of heavy metals with crystalline iron oxides in the polluted soils around the mining areas in Guangdong Province, China.

Yin H, Tan N, Liu C, Wang J, Liang X, Qu M, Feng X, Qiu G, Tan W, Liu F.

Chemosphere. 2016 Oct;161:181-189. doi: 10.1016/j.chemosphere.2016.07.018. Epub 2016 Jul 17.

PMID:
27427775
42.

Effects of Al(3+) doping on the structure and properties of goethite and its adsorption behavior towards phosphate.

Li W, Wang L, Liu F, Liang X, Feng X, Tan W, Zheng L, Yin H.

J Environ Sci (China). 2016 Jul;45:18-27. doi: 10.1016/j.jes.2015.12.013. Epub 2016 Feb 1.

PMID:
27372115
43.

The induction of apoptosis in HepG-2 cells by ruthenium(II) complexes through an intrinsic ROS-mediated mitochondrial dysfunction pathway.

Zeng CC, Lai SH, Yao JH, Zhang C, Yin H, Li W, Han BJ, Liu YJ.

Eur J Med Chem. 2016 Oct 21;122:118-126. doi: 10.1016/j.ejmech.2016.06.020. Epub 2016 Jun 15.

PMID:
27344489
44.

Synthesis, characterization and anticancer activity studies of ruthenium(II) polypyridyl complexes on A549 cells.

Zeng CC, Jiang GB, Lai SH, Zhang C, Yin H, Tang B, Wan D, Liu YJ.

J Photochem Photobiol B. 2016 Aug;161:295-303. doi: 10.1016/j.jphotobiol.2016.06.004. Epub 2016 Jun 5.

PMID:
27288660
45.

Androgen Deprivation Therapy and the Incidence of Inflammatory Bowel Disease in Patients With Prostate Cancer.

Klil-Drori AJ, Tascilar K, Yin H, Aprikian A, Bitton A, Azoulay L.

Am J Epidemiol. 2016 Jul 1;184(1):15-22. doi: 10.1093/aje/kwv307. Epub 2016 Jun 6.

46.

Influencing factors associated with the mode of birth among childbearing women in Hunan Province: a cross-sectional study in China.

Shi Y, Jiang Y, Zeng Q, Yuan Y, Yin H, Chang C, Pang R.

BMC Pregnancy Childbirth. 2016 May 16;16:108. doi: 10.1186/s12884-016-0897-9.

47.

Phosphodiesterase Type 5 Inhibitors and the Risk of Melanoma Skin Cancer.

Lian Y, Yin H, Pollak MN, Carrier S, Platt RW, Suissa S, Azoulay L.

Eur Urol. 2016 Nov;70(5):808-815. doi: 10.1016/j.eururo.2016.04.035. Epub 2016 May 10.

PMID:
27178449
48.

Sonoluminescence characterization of inertial cavitation inside a BSA phantom treated by pulsed HIFU.

Yin H, Chang N, Xu S, Wan M.

Ultrason Sonochem. 2016 Sep;32:158-164. doi: 10.1016/j.ultsonch.2016.02.025. Epub 2016 Mar 2.

PMID:
27150756
49.

Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study.

Azoulay L, Soldera S, Yin H, Bouganim N.

Epidemiology. 2016 Jul;27(4):594-601. doi: 10.1097/EDE.0000000000000483.

PMID:
27031042
50.

Pioglitazone use and risk of bladder cancer: population based cohort study.

Tuccori M, Filion KB, Yin H, Yu OH, Platt RW, Azoulay L.

BMJ. 2016 Mar 30;352:i1541. doi: 10.1136/bmj.i1541.

Supplemental Content

Loading ...
Support Center